Overall, our findings support a model in which Nedd4-2 regulates glutamate transporter function to modulate the effects of PD, and SGK and PKC reciprocally regulate Nedd4-2 activity (Figure 8c). This evidence concerns the gene PRRT2 and Parkinson disease.